<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>T cell lymphoma, cutaneous</title><link>http://www.unboundmedicine.com/medline/ebm/research/T_cell_lymphoma,_cutaneous</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19048251/full_citation/Defucosylated_anti_CCR4_monoclonal_antibody_exercises_potent_ADCC_mediated_antitumor_effect_in_the_novel_tumor_bearing_humanized_NOD/Shi_scid_IL_2Rgamma_null__mouse_model_</link><description>Ito A, Ishida T, Yano H, et al. <br/><span class="title">Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer immunology, immunotherapy : CII">Cancer Immunol Immunother 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19048251/abstract/Defucosylated_anti_CCR4_monoclonal_antibody_exercises_potent_ADCC_mediated_antitumor_effect_in_the_novel_tumor_bearing_humanized_NOD/Shi_scid_IL_2Rgamma_null__mouse_model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19048251/full_citation/Defucosylated_anti_CCR4_monoclonal_antibody_exercises_potent_ADCC_mediated_antitumor_effect_in_the_novel_tumor_bearing_humanized_NOD/Shi_scid_IL_2Rgamma_null__mouse_model_">Full Citation</a></description></item><item><title>Fatal Subcutaneous Panniculitis-Like T-Cell Lymphoma gamma/delta Subtype (Cutaneous gamma/delta T-Cell Lymphoma): Report of a Case and Review of the Literature.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19033937/full_citation/Fatal_Subcutaneous_Panniculitis_Like_T_Cell_Lymphoma_gamma/delta_Subtype__Cutaneous_gamma/delta_T_Cell_Lymphoma_:_Report_of_a_Case_and_Review_of_the_Literature_</link><description>Kao GF, Resh B, McMahon C, et al. <br/><span class="title">Fatal Subcutaneous Panniculitis-Like T-Cell Lymphoma gamma/delta Subtype (Cutaneous gamma/delta T-Cell Lymphoma): Report of a Case and Review of the Literature. [JOURNAL ARTICLE]</span><br/><span class="source" title="The American Journal of dermatopathology">Am J Dermatopathol 2008 Dec; 30(6):593-599.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19033937/abstract/Fatal_Subcutaneous_Panniculitis_Like_T_Cell_Lymphoma_gamma/delta_Subtype__Cutaneous_gamma/delta_T_Cell_Lymphoma_:_Report_of_a_Case_and_Review_of_the_Literature_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19033937/full_citation/Fatal_Subcutaneous_Panniculitis_Like_T_Cell_Lymphoma_gamma/delta_Subtype__Cutaneous_gamma/delta_T_Cell_Lymphoma_:_Report_of_a_Case_and_Review_of_the_Literature_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19033937/Fatal_Subcutaneous_Panniculitis_Like_T_Cell_Lymphoma_gamma/delta_Subtype__Cutaneous_gamma/delta_T_Cell_Lymphoma_:_Report_of_a_Case_and_Review_of_the_Literature_">Find Related Articles</a> </description></item><item><title>Primary cutaneous B-cell lymphoma, leg type restricted to the subcutaneous fat arising in a patient with dermatomyositis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19033933/full_citation/Primary_cutaneous_B_cell_lymphoma_leg_type_restricted_to_the_subcutaneous_fat_arising_in_a_patient_with_dermatomyositis_</link><description>Levy A, Randall MB, Henson T <br/><span class="title">Primary cutaneous B-cell lymphoma, leg type restricted to the subcutaneous fat arising in a patient with dermatomyositis. [Journal Article]</span><br/><span class="source" title="The American Journal of dermatopathology">Am J Dermatopathol 2008 Dec; 30(6):578-81.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19033933/abstract/Primary_cutaneous_B_cell_lymphoma_leg_type_restricted_to_the_subcutaneous_fat_arising_in_a_patient_with_dermatomyositis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19033933/full_citation/Primary_cutaneous_B_cell_lymphoma_leg_type_restricted_to_the_subcutaneous_fat_arising_in_a_patient_with_dermatomyositis_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19033933/Primary_cutaneous_B_cell_lymphoma_leg_type_restricted_to_the_subcutaneous_fat_arising_in_a_patient_with_dermatomyositis_">Find Related Articles</a> </description></item><item><title>[Diagnostic significance of immunophenotyping and detection of gene rearrangement in subcutaneous panniculitis-like T-cell lymphoma]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19031718/full_citation/[Diagnostic_significance_of_immunophenotyping_and_detection_of_gene_rearrangement_in_subcutaneous_panniculitis_like_T_cell_lymphoma]</link><description>Wan C, Xu C, Wang L, et al. <br/><span class="title">[Diagnostic significance of immunophenotyping and detection of gene rearrangement in subcutaneous panniculitis-like T-cell lymphoma] [English Abstract, Journal Article]</span><br/><span class="source" title="Zhonghua bing li xue za zhi Chinese journal of pathology">Zhonghua Bing Li Xue Za Zhi 2008 Jun; 37(6):390-4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19031718/abstract/[Diagnostic_significance_of_immunophenotyping_and_detection_of_gene_rearrangement_in_subcutaneous_panniculitis_like_T_cell_lymphoma]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19031718/full_citation/[Diagnostic_significance_of_immunophenotyping_and_detection_of_gene_rearrangement_in_subcutaneous_panniculitis_like_T_cell_lymphoma]">Full Citation</a></description></item><item><title>Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19026464/full_citation/Poor_prognosis_in_non_Caucasian_patients_with_early_onset_mycosis_fungoides_</link><description>Sun G, Berthelot C, Li Y, et al. <br/><span class="title">Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the American Academy of Dermatology">J Am Acad Dermatol 2008 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19026464/abstract/Poor_prognosis_in_non_Caucasian_patients_with_early_onset_mycosis_fungoides_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19026464/full_citation/Poor_prognosis_in_non_Caucasian_patients_with_early_onset_mycosis_fungoides_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(08)01373-X">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19026464/Poor_prognosis_in_non_Caucasian_patients_with_early_onset_mycosis_fungoides_">Find Related Articles</a> </description></item><item><title>Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: Clinicopathological analysis of 27 patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19018763/full_citation/Primary_cutaneous_T_cell_lymphoma_of_unspecified_type_with_cytotoxic_phenotype:_Clinicopathological_analysis_of_27_patients_</link><description>Hagiwara M, Takata K, Shimoyama Y, et al. <br/><span class="title">Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: Clinicopathological analysis of 27 patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer science">Cancer Sci 2008 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19018763/abstract/Primary_cutaneous_T_cell_lymphoma_of_unspecified_type_with_cytotoxic_phenotype:_Clinicopathological_analysis_of_27_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19018763/full_citation/Primary_cutaneous_T_cell_lymphoma_of_unspecified_type_with_cytotoxic_phenotype:_Clinicopathological_analysis_of_27_patients_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19018763/Primary_cutaneous_T_cell_lymphoma_of_unspecified_type_with_cytotoxic_phenotype:_Clinicopathological_analysis_of_27_patients_">Find Related Articles</a> </description></item><item><title>Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19016373/full_citation/Evaluation_of_the_efficacy_of_the_combination_of_oral_bexarotene_and_methotrexate_for_the_treatment_of_early_stage_treatment_refractory_cutaneous_T_cell_lymphoma_</link><description>Kannangara AP, Levitan D, Fleischer AB <br/><span class="title">Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of dermatological treatment">J Dermatolog Treat 2008 Nov 18.:1-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19016373/abstract/Evaluation_of_the_efficacy_of_the_combination_of_oral_bexarotene_and_methotrexate_for_the_treatment_of_early_stage_treatment_refractory_cutaneous_T_cell_lymphoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19016373/full_citation/Evaluation_of_the_efficacy_of_the_combination_of_oral_bexarotene_and_methotrexate_for_the_treatment_of_early_stage_treatment_refractory_cutaneous_T_cell_lymphoma_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19016373/Evaluation_of_the_efficacy_of_the_combination_of_oral_bexarotene_and_methotrexate_for_the_treatment_of_early_stage_treatment_refractory_cutaneous_T_cell_lymphoma_">Find Related Articles</a> </description></item><item><title>Extranodal NK / T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups- a retrospective study of 18 patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014396/full_citation/Extranodal_NK_/_T_cell_lymphoma_with_cutaneous_involvement:_'nasal'_vs__'nasal_type'_subgroups__a_retrospective_study_of_18_patients_</link><description>Choi YL, Park JH, Namkung JH, et al. <br/><span class="title">Extranodal NK / T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups- a retrospective study of 18 patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="The British journal of dermatology">Br J Dermatol 2008 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014396/abstract/Extranodal_NK_/_T_cell_lymphoma_with_cutaneous_involvement:_'nasal'_vs__'nasal_type'_subgroups__a_retrospective_study_of_18_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014396/full_citation/Extranodal_NK_/_T_cell_lymphoma_with_cutaneous_involvement:_'nasal'_vs__'nasal_type'_subgroups__a_retrospective_study_of_18_patients_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19014396/Extranodal_NK_/_T_cell_lymphoma_with_cutaneous_involvement:_'nasal'_vs__'nasal_type'_subgroups__a_retrospective_study_of_18_patients_">Find Related Articles</a> </description></item><item><title>Histone deacetylase inhibitors as novel anticancer therapeutics.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19008999/full_citation/Histone_deacetylase_inhibitors_as_novel_anticancer_therapeutics_</link><description>Walkinshaw DR, Yang XJ <br/><span class="title">Histone deacetylase inhibitors as novel anticancer therapeutics. [Journal Article]</span><br/><span class="source" title="Current oncology (Toronto, Ont.)">Curr Oncol 2008 Oct; 15(5):237-43.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19008999/abstract/Histone_deacetylase_inhibitors_as_novel_anticancer_therapeutics_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19008999/full_citation/Histone_deacetylase_inhibitors_as_novel_anticancer_therapeutics_">Full Citation</a></description></item><item><title>The balance between immunity and tolerance: The role of Langerhans cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19002380/full_citation/The_balance_between_immunity_and_tolerance:_The_role_of_Langerhans_cells_</link><description>Mutyambizi K, Berger CL, Edelson RL <br/><span class="title">The balance between immunity and tolerance: The role of Langerhans cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cellular and molecular life sciences : CMLS">Cell Mol Life Sci 2008 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19002380/abstract/The_balance_between_immunity_and_tolerance:_The_role_of_Langerhans_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19002380/full_citation/The_balance_between_immunity_and_tolerance:_The_role_of_Langerhans_cells_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19002380/The_balance_between_immunity_and_tolerance:_The_role_of_Langerhans_cells_">Find Related Articles</a> </description></item></channel></rss>